Literature DB >> 23332826

Sensing of cell death by myeloid C-type lectin receptors.

David Sancho1, Caetano Reis e Sousa.   

Abstract

Molecules associated with dead or dying cells can be detected by receptors on macrophages and dendritic cells. Signals from these receptors impact myeloid cell function and play a role in determining whether death is silent or proinflammatory, tolerogenic or immunogenic. Prominent among myeloid receptors detecting dead cells are C-type lectin receptors (CLRs). Signals from these receptors variably induce endocytosis of cell corpses, corpse degradation, retrieval of dead cell-associated antigens and/or modulation of immune responses. The sensing of tissue damage by myeloid CLRs complements detection of pathogens in immunity and represents an ancient response aimed at restoring tissue homeostasis.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23332826      PMCID: PMC4480265          DOI: 10.1016/j.coi.2012.12.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  52 in total

1.  Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.

Authors:  Sven Burgdorf; Andreas Kautz; Volker Böhnert; Percy A Knolle; Christian Kurts
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

2.  Toll-like receptor 3 promotes cross-priming to virus-infected cells.

Authors:  Oliver Schulz; Sandra S Diebold; Margaret Chen; Tanja I Näslund; Martijn A Nolte; Lena Alexopoulou; Yasu-Taka Azuma; Richard A Flavell; Peter Liljeström; Caetano Reis e Sousa
Journal:  Nature       Date:  2005-02-13       Impact factor: 49.962

Review 3.  C-type lectin-like domains.

Authors:  K Drickamer
Journal:  Curr Opin Struct Biol       Date:  1999-10       Impact factor: 6.809

4.  The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments.

Authors:  Jian-Guo Zhang; Peter E Czabotar; Antonia N Policheni; Irina Caminschi; Soo San Wan; Susie Kitsoulis; Kirsteen M Tullett; Adeline Y Robin; Rajini Brammananth; Mark F van Delft; Jinhua Lu; Lorraine A O'Reilly; Emma C Josefsson; Benjamin T Kile; Wei Jin Chin; Justine D Mintern; Maya A Olshina; Wilson Wong; Jake Baum; Mark D Wright; David C S Huang; Narla Mohandas; Ross L Coppel; Peter M Colman; Nicos A Nicola; Ken Shortman; Mireille H Lahoud
Journal:  Immunity       Date:  2012-04-05       Impact factor: 31.745

5.  Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients.

Authors:  Nobuo Nakamura; Yasunori Shimaoka; Takahiro Tougan; Hiroaki Onda; Daisuke Okuzaki; Hanjun Zhao; Azumi Fujimori; Norikazu Yabuta; Ippei Nagamori; Akie Tanigawa; Jun Sato; Takenori Oda; Kenji Hayashida; Ryuji Suzuki; Masao Yukioka; Hiroshi Nojima; Takahiro Ochi
Journal:  DNA Res       Date:  2006-08-31       Impact factor: 4.458

6.  The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.

Authors:  Irina Caminschi; Anna I Proietto; Fatma Ahmet; Susie Kitsoulis; Joo Shin Teh; Jennifer C Y Lo; Alexandra Rizzitelli; Li Wu; David Vremec; Serani L H van Dommelen; Ian K Campbell; Eugene Maraskovsky; Hal Braley; Gayle M Davey; Patricia Mottram; Nicholas van de Velde; Kent Jensen; Andrew M Lew; Mark D Wright; William R Heath; Ken Shortman; Mireille H Lahoud
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

Review 7.  Clearance of apoptotic cells: implications in health and disease.

Authors:  Michael R Elliott; Kodi S Ravichandran
Journal:  J Cell Biol       Date:  2010-06-28       Impact factor: 10.539

8.  Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.

Authors:  David Sancho; Diego Mourão-Sá; Olivier P Joffre; Oliver Schulz; Neil C Rogers; Daniel J Pennington; James R Carlyle; Caetano Reis e Sousa
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

9.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

10.  The induction of tolerance by dendritic cells that have captured apoptotic cells.

Authors:  R M Steinman; S Turley; I Mellman; K Inaba
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  31 in total

1.  SIGNR3-dependent immune regulation by Lactobacillus acidophilus surface layer protein A in colitis.

Authors:  Yaíma L Lightfoot; Kurt Selle; Tao Yang; Yong Jun Goh; Bikash Sahay; Mojgan Zadeh; Jennifer L Owen; Natacha Colliou; Eric Li; Timo Johannssen; Bernd Lepenies; Todd R Klaenhammer; Mansour Mohamadzadeh
Journal:  EMBO J       Date:  2015-02-09       Impact factor: 11.598

Review 2.  Discrimination of Self and Non-Self Ribonucleic Acids.

Authors:  Anna Gebhardt; Beatrice T Laudenbach; Andreas Pichlmair
Journal:  J Interferon Cytokine Res       Date:  2017-05       Impact factor: 2.607

3.  Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses.

Authors:  Ryoko Kiyotake; Masatsugu Oh-Hora; Eri Ishikawa; Tomofumi Miyamoto; Tatsuro Ishibashi; Sho Yamasaki
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

4.  Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview.

Authors:  Jiri Gallo; Milan Raska; Yrjo T Konttinen; Christophe Nich; Stuart B Goodman
Journal:  J Long Term Eff Med Implants       Date:  2014

5.  Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34+ Acute Myeloid Leukemia.

Authors:  Yan-Yu Wang; Wen-Lian Chen; Xiang-Qin Weng; Yan Sheng; Jing Wu; Jie Hao; Zhan-Yun Liu; Yong-Mei Zhu; Bing Chen; Shu-Min Xiong; Yu Chen; Qiu-Sheng Chen; Hui-Ping Sun; Jun-Min Li; Jin Wang
Journal:  Stem Cells Dev       Date:  2017-09-21       Impact factor: 3.272

6.  Intracellular metabolite β-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity.

Authors:  Masahiro Nagata; Yoshihiro Izumi; Eri Ishikawa; Ryoko Kiyotake; Rieko Doi; Satoru Iwai; Zakaria Omahdi; Toshiyuki Yamaji; Tomofumi Miyamoto; Takeshi Bamba; Sho Yamasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

7.  MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88.

Authors:  C Benito-Villalvilla; C Cirauqui; C M Diez-Rivero; M Casanovas; J L Subiza; O Palomares
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

Review 8.  Dendritic-cell-based therapeutic cancer vaccines.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

9.  Structural analysis for glycolipid recognition by the C-type lectins Mincle and MCL.

Authors:  Atsushi Furukawa; Jun Kamishikiryo; Daiki Mori; Kenji Toyonaga; Yuki Okabe; Aya Toji; Ryo Kanda; Yasunobu Miyake; Toyoyuki Ose; Sho Yamasaki; Katsumi Maenaka
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

10.  Helminth infections decrease host susceptibility to immune-mediated diseases.

Authors:  Joel V Weinstock; David E Elliott
Journal:  J Immunol       Date:  2014-10-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.